T-cell exhaustion due to chronic tumour antigen stimulation can be successfully overcome via immune checkpoint blockade (ICB) targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed cell death-1 (PD-1), or programmed cell death ligand-1 (PD-L1)6,7. Here, CD274 is linked to neoplasm.